Forbes: HPV vaccination still going strong after 10 years

New findings from one of the longest follow-up studies of the four-strain human papilloma virus (HPV) show that the vaccine is safe and effective, especially in those who received the vaccine at a younger age.

“These findings justify efforts to vaccinate subjects at the earliest opportunity,” said Dr. Daron Ferris, professor of obstetrics and gynecology at the Medical College of Georgia at Augusta University. “Moreover, by vaccinating preadolescents before exposure to HPV, the full potential of the vaccine is more likely to be realized.”

The research was featured in multiple national publications, including Forbes, Yahoo News! and MSN.

Forbes: HPV Vaccination Immunity Remains Strong 10 Years Later, Especially For Preteens

Nov. 22, 2017

Like Love Haha Wow Sad Angry
Written by
Emily Lacey

Emily Lacey is a writer in the Division of Communications & Marketing at Augusta University. Contact her to schedule an interview on this topic or with one of our experts at 706-721-6144

View all articles
Written by Emily Lacey

Jagwire is your source for news and stories from Augusta University and AU Health. Daily updates highlight the many ways students, faculty, staff, researchers and clinicians "bring their A games" in classrooms and clinics on four campuses in Augusta and locations across the state of Georgia.

Read on for stories of innovation in education and health care, opportunities at the center of Georgia’s new cybersecurity hub, and experiential learning that blends arts and application, humanities and the health sciences.